#United States #San Francisco #Securities Class Action #Hagens Berman #Ardent Health

Ardent Health Faces Securities Class Action

In a significant development for investors in Ardent Health, Inc. (NYSE: ARDT), the national law firm Hagens Berman has raised alarms regarding a pending securities class action against the company. The firm is seeking to notify shareholders about a critical deadline approaching on March 9, 2026, as part of ongoing litigation that focuses on alarming accusations related to the company’s accounting practices.

Key Allegations

The crux of the allegations against Ardent Health centers on its financial disclosures surrounding reserve accounting practices. Specifically, in November 2025, the company acknowledged that it had utilized a rigid "180-day cliff" method for reserving uncollectible accounts. This approach conflicts starkly with previous statements from the company, which had maintained that it relied on detailed historical reviews of collections to assess the value of its receivables. This revelation led to a staggering 33% drop in the company’s stock, highlighting the severe impact of such disclosures on investor confidence.

Hagens Berman asserts that Ardent may have delayed recognizing substantial losses, artificially inflating its earnings profile during its initial months as a publicly traded entity. The implications of such alleged practices raise the specter of significant legal consequences for both the company and its top executives.

Underlying Issues

The pending litigation unfolds against a backdrop of several critical financial discrepancies:

1. The 180-Day Cliff: The legal action claims that Ardent did not primarily depend on the touted detailed reviews but instead employed a method that allowed accounts to be fully reserved only after they aged 180 days. This significantly inflated the company's reported receivables during the class period.

2. Insufficient Insurance Reserves: The suit alleges that the company failed to maintain an adequate level of malpractice liability insurance, which further exacerbated the claims against it.

3. Revenue Reduction: In a major accounting shift revealed on November 12, 2025, Ardent slashed approximately $42.6 million from its revenue, correlating to adjustments made in its accounts receivable collectability estimates.

4. Unprecedented Liability Increases: The company experienced a sharp $54 million rise in its professional liability reserves, attributed to recent settlements and ongoing lawsuits from between 2019 and 2022, particularly highlighting trends of social inflation impacting their liabilities.

These issues contributed to the substantial decline in Ardent Health’s stock price following the November disclosures, ultimately redefining the trust investors had in the company’s fiscal management and establishing the foundation for the class action suit.

Next Steps for Investors

Hagens Berman's lead partner on the case, Reed Kathrein, is actively involved in guiding investors who purchased ARDT shares between the timeframe of July 18, 2024, to November 12, 2025. Potential class members are encouraged to reach out to the firm to assess their losses and understand their options moving forward. The firm specializes in complex securities litigation and has a reputable track record for holding corporations accountable for their actions.

Hagens Berman’s expertise is complemented by a comprehensive legal approach for shareholders aiming to recover their losses stemming from alleged corporate malfeasance. Investors are invited to submit their claims through secure channels to ensure that their interests are represented as this situation unfolds.

In conclusion, the situation surrounding Ardent Health serves as a vivid reminder of the essential need for transparency within corporate financial practices and the potential consequences when trust is compromised. For individuals or stakeholders impacted by this case, the urgency to act before the impending deadline cannot be overstated.